Eletriptan hydrobromide

Overview

Eletriptan hydrobromide (Eletriptan HBr) is a 5-HT 1B and 5-HT 1D receptor agonist with antimigraine activity, with K i of 0.92 nM and 3.14 nM, respectively.

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > 5-HT Receptor

Product Information

• Catalog No.: HY-A0010
• CAS No.: 177834-92-3
• Molecular Formula: C22H27BrN2O2S
• Molecular Weight: 463.43
• Purity: 99.33%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.75 mg/mL (5.93 mM); Clear solution
• Availability: In-stock

Source

Original product source